Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Egypt.
Campus
Science
Patient Support
Products
Events
Login
Registration
Science
Cardiovascular
Diabetes
Rare Diseases
Vaccines
Asthma
Cardiovascular
Thrombosis
Hypertension
Dyslipidemia
Atherothrombosis
Diabetes
Sanofi's Insulin Legacy & Heritage
Time in Range
Patient Support
Cardiovascular
Diabetes
Atopic Dermatitis
Nasal Polyps
Asthma
Products
Clexane®
Soliqua®
Depakine®
Dapaglif®
Dupixent®
Toujeo®
Praluent®
Plavix®
Clexane®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
Proximal deep vein thrombosis
One day surgery & fast track surgery Thromboprophylaxis Guidelines
Soliqua®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Dapaglif®
Dapaglif®
Dapaglif®
Dupixent®
Dupixent Atopic Dermatitis
Dupixent® Asthma
Dupixent® Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Ocs Use
Type 2 Asthma With Comorbidities
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Toujeo®
Time in Range Results
OAD Uncontrolled Patients
Premix Uncontrolled Patients
Time In Range
Praluent®
Know about praluent
Plavix®
The Cure Study
PCI Cure Study
Plavix New Indication
Events
Guide Deep
Guide Wave 8
Guide Wave 9
Campus
Science
Patient Support
Products
Events
Back to Main
Science
Cardiovascular
Diabetes
Rare Diseases
Vaccines
Asthma
Science
Cardiovascular
Thrombosis
Hypertension
Dyslipidemia
Atherothrombosis
Science
Diabetes
Sanofi's Insulin Legacy & Heritage
Time in Range
Back to Main
Patient Support
Cardiovascular
Diabetes
Atopic Dermatitis
Nasal Polyps
Asthma
Back to Main
Products
Clexane®
Soliqua®
Depakine®
Dapaglif®
Dupixent®
Toujeo®
Praluent®
Plavix®
Products
Clexane®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
Proximal deep vein thrombosis
One day surgery & fast track surgery thromboprophylaxis Guidelines
Products
Soliqua®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Products
Dapaglif®
Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
Products
Dupixent®
Dupixent Atopic Dermatitis
Dupixent® Asthma
Dupixent®
Dupixent® Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Mixed Biomarkers
Type 2 Asthma With Comorbidities
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Products
Toujeo®
Time in Range Results
OAD Uncontrolled Patients
Premix Uncontrolled Patients
Time In Range
Products
Praluent®
Know about praluent
Products
Plavix®
The Cure Study
PCI Cure Study
Plavix New Indication
Back to Main
Events
Guide Deep
Guide Wave 8
Guide Wave 9
Login
Registration
Home
Patient Support
Asthma
Dupixent FAQ Patient Booklet
Dupixent FAQ Patient Booklet
Dupixent FAQ
Related articles
Dupixent How to Use Patient Booklet
Learn more
Dupixent My Way Program
Learn more
Bronchial Asthma Patient Educational Flyer
Learn more
MAT-EG-2101731